Glanbia : Expected recovery in GPN and NS volumes in Q4. CMD scheduled for 9 November
>Strong organic growth of 21.7% in the first nine months with a slowdown in Q3 due to the more pronounced fall in GPN and NS volumes - Glanbia yesterday released its interim management statement for the first nine months. Organic sales growth stood at +21.7% with a 20.9% price effect and a 0.8% volume effect. Glanbia Performance Nutrition (GPN) showed organic growth of 13.2% with an acceleration in the price effect to 15.4% while volumes were down 2.2% (vs +0.5% in H...Glanbia is a performance nutrition and ingredients group, engaged in providing performance nutrition, cheese, dairy ingredients, specialty non-dairy ingredients and vitamin and mineral premixes. Co. segments include: Global Performance Nutrition, which is involved in the branded performance nutrition business; Global Ingredients, which manufactures cheddar cheese, provides dairy and non-dairy nutritional ingredients and micro-nutrient premixes; Dairy Ireland, which is engaged in the manufacture and sale of a range of consumer products and farm inputs; and Joint Ventures & Associates, which is engaged in the manufacture and sale of cheese, dairy ingredients and dairy consumer products.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.